Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns.
Queran Lin, Tingxi Ye, Pengpeng Ye, Claudio Borghi, Suzie Cro, Albertino Damasceno, Nadia Khan, Peter M Nilsson, Dorairaj Prabhakaran, Agustin Ramirez, Markus P Schlaich, Aletta E Schutte, George Stergiou, Michael A Weber, Thomas Beaney, Neil R Poulter
{"title":"Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns.","authors":"Queran Lin, Tingxi Ye, Pengpeng Ye, Claudio Borghi, Suzie Cro, Albertino Damasceno, Nadia Khan, Peter M Nilsson, Dorairaj Prabhakaran, Agustin Ramirez, Markus P Schlaich, Aletta E Schutte, George Stergiou, Michael A Weber, Thomas Beaney, Neil R Poulter","doi":"10.1016/S2214-109X(22)00238-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Blood pressure control has a pivotal role in reducing the incidence and recurrence of stroke. May Measurement Month (MMM), which was initiated in 2017 by the International Society of Hypertension, is the largest global blood pressure screening campaign. We aim to compare MMM participants with and without a previous history of stroke and to investigate associations between national-level estimates of blood pressure management from MMM and premature stroke mortality.</p><p><strong>Methods: </strong>In this annual, global, cross-sectional survey, more than 2·5 million volunteers (≥18 years) from 92 countries were screened in May, 2017, and May, 2018. Three seated blood pressure readings and demographic, lifestyle, and cardiovascular disease data were collected. Associations between risk factors and stroke history were analysed with mixed-effects logistic regression, and associations between national-level estimates of blood pressure management and premature stroke mortality based on Global Burden of Disease data were investigated with linear regression.</p><p><strong>Findings: </strong>2 222 399 (88·4%) of 2 515 365 participants had recorded data on a history of stroke, of whom 62 639 (2·8%) reported a previous stroke. Participants with a history of stroke had higher rates of hypertension (77·0% vs 32·9%, p<0·0001) and of treated (90·2% vs 57·0%, p<0·0001) and controlled (55·9% vs 32·4%, p<0·0001) hypertension than those without a history of stroke. A third of participants with a history of stroke had either untreated hypertension or treated but uncontrolled hypertension (blood pressure ≥140/90 mm Hg). Strong positive associations were found between national premature stroke mortality and mean systolic blood pressure (84·3 [95% CI 38·8 to 129·9] years of life lost [YLL] per 100 000 people per mm Hg increase) and the percentage of participants with raised blood pressure (49·1 [22·6 to 75·6] YLL per 100 000 people per 1% increase). Strong negative associations were found between national premature stroke mortality and the percentage of participants with hypertension on treatment (-21·0 [-33·0 to -8·9] YLL per 100 000 people per 1% increase) and with controlled blood pressure (-31·6 [-43·8 to -19·4] YLL per 100 000 people per 1% increase).</p><p><strong>Interpretation: </strong>Blood pressure control remains suboptimal worldwide among people with a history of stroke. National estimates of blood pressure management reflect national premature stroke mortality sufficiently to prompt policy makers to promote blood pressure screening and management.</p><p><strong>Funding: </strong>International Society of Hypertension and Servier Pharmaceuticals.</p>","PeriodicalId":153380,"journal":{"name":"The Lancet. Global health","volume":" ","pages":"e1141-e1149"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Global health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/S2214-109X(22)00238-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11
Abstract
Background: Blood pressure control has a pivotal role in reducing the incidence and recurrence of stroke. May Measurement Month (MMM), which was initiated in 2017 by the International Society of Hypertension, is the largest global blood pressure screening campaign. We aim to compare MMM participants with and without a previous history of stroke and to investigate associations between national-level estimates of blood pressure management from MMM and premature stroke mortality.
Methods: In this annual, global, cross-sectional survey, more than 2·5 million volunteers (≥18 years) from 92 countries were screened in May, 2017, and May, 2018. Three seated blood pressure readings and demographic, lifestyle, and cardiovascular disease data were collected. Associations between risk factors and stroke history were analysed with mixed-effects logistic regression, and associations between national-level estimates of blood pressure management and premature stroke mortality based on Global Burden of Disease data were investigated with linear regression.
Findings: 2 222 399 (88·4%) of 2 515 365 participants had recorded data on a history of stroke, of whom 62 639 (2·8%) reported a previous stroke. Participants with a history of stroke had higher rates of hypertension (77·0% vs 32·9%, p<0·0001) and of treated (90·2% vs 57·0%, p<0·0001) and controlled (55·9% vs 32·4%, p<0·0001) hypertension than those without a history of stroke. A third of participants with a history of stroke had either untreated hypertension or treated but uncontrolled hypertension (blood pressure ≥140/90 mm Hg). Strong positive associations were found between national premature stroke mortality and mean systolic blood pressure (84·3 [95% CI 38·8 to 129·9] years of life lost [YLL] per 100 000 people per mm Hg increase) and the percentage of participants with raised blood pressure (49·1 [22·6 to 75·6] YLL per 100 000 people per 1% increase). Strong negative associations were found between national premature stroke mortality and the percentage of participants with hypertension on treatment (-21·0 [-33·0 to -8·9] YLL per 100 000 people per 1% increase) and with controlled blood pressure (-31·6 [-43·8 to -19·4] YLL per 100 000 people per 1% increase).
Interpretation: Blood pressure control remains suboptimal worldwide among people with a history of stroke. National estimates of blood pressure management reflect national premature stroke mortality sufficiently to prompt policy makers to promote blood pressure screening and management.
Funding: International Society of Hypertension and Servier Pharmaceuticals.
背景:血压控制对降低脑卒中的发病率和复发率具有关键作用。国际高血压学会于2017年发起的“五月测量月”(MMM)是全球最大的血压筛查活动。我们的目的是比较有和没有中风史的MMM参与者,并调查全国范围内MMM血压管理估计值与过早中风死亡率之间的关系。方法:在这项年度全球横断面调查中,于2017年5月和2018年5月对来自92个国家的250多万名志愿者(≥18岁)进行了筛查。收集了三个坐姿血压读数以及人口统计、生活方式和心血管疾病数据。使用混合效应logistic回归分析危险因素与卒中史之间的关联,并使用线性回归调查基于全球疾病负担数据的国家级血压管理估计值与过早卒中死亡率之间的关联。结果:2515365名参与者中有222399人(88.4%)有卒中史记录,其中62639人(2.8%)报告有卒中史。有脑卒中史的参与者有更高的高血压率(77.0% vs 32.9%)。解释:在世界范围内,有脑卒中史的人群血压控制仍处于次优状态。全国血压管理估计足以反映全国过早中风死亡率,从而促使决策者促进血压筛查和管理。资助:国际高血压学会和施维雅制药公司。